2/28
01:10 pm
zntl
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $46.00 price target on the stock.
Medium
Report
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $46.00 price target on the stock.
2/28
07:59 am
zntl
Rating for ZNTL
Medium
Report
Rating for ZNTL
2/28
07:59 am
zntl
Rating for ZNTL
Medium
Report
Rating for ZNTL